Dawn Stoner
Adult Health · Bonita Springs, FLNPI 1376869305
Payments from drug & device makers
Across 269 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xeris Pharmaceuticals, Inc.$1K
- Insulet Corporation$695
- Sanofi-aventis U.S. LLC$402
- Novo Nordisk$392
- Boehringer Ingelheim$387
- Lilly USA, LLC$357
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,632100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 34 | $1,249 |
| Insulet Corporation | 14 | $695 |
| Sanofi-aventis U.S. LLC | 20 | $402 |
| Novo Nordisk | 22 | $392 |
| Boehringer Ingelheim | 25 | $387 |
| Lilly USA, LLC | 22 | $357 |
| Dexcom, Inc. | 14 | $338 |
| Tandem Diabetes Care, Inc. | 9 | $333 |
| Medtronic | 7 | $301 |
| Bayer | 11 | $258 |
| Novartis | 13 | $248 |
| Mannkind Corporation | 15 | $229 |
| Merck | 8 | $153 |
| Astellas Pharma US Inc | 1 | $140 |
| AstraZeneca(2 entities) | 7 | $121 |
| Recordati_rare_diseases_inc. | 4 | $97 |
| Corcept Therapeutics | 5 | $95 |
| BETA Bionics, Inc. | 4 | $86 |
| United Therapeutics Corporation | 1 | $86 |
| Madrigal Pharmaceuticals | 3 | $81 |
| Antares Pharma, Inc. | 4 | $81 |
| Amgen | 4 | $75 |
| Sequel Med Tech, LLC | 2 | $61 |
| Zealand Pharma US, Inc. | 2 | $40 |
| AbbVie | 2 | $36 |
| GSK | 1 | $34 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Abbott | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Nevro Corp. | 1 | $26 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Lifescan, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GVOKE PFS$226
- Omnipod$208
- Veozah$140
- MINIMED 780G$128
- t:slim X2 Insulin Pump with Control-IQ$100
How this compares
$6,632 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $126,021 |
| MounjaroTirzepatide | 85 | $124,485 |
| JardianceEmpagliflozin | 74 | $103,719 |
| JanuviaSitagliptin Phosphate | 39 | $38,290 |
| TrulicityDulaglutide | 16 | $28,308 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $24,510 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 11 | $24,004 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 18 | $19,979 |
| TradjentaLinagliptin | 11 | $17,215 |
| Novolog FlexpenInsulin Aspart | 45 | $11,664 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 64 | $8,958 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $7,590 |
| NovologInsulin Aspart | 19 | $6,279 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $6,113 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 17 | $5,317 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $357 | $152,792101 claims |
| Novo NordiskOzempic, Novolog | $392 | $132,300113 claims |
| Boehringer IngelheimJardiance, Tradjenta | $387 | $120,93485 claims |
| MerckJanuvia | $153 | $38,29039 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $402 | $19,97918 claims |
| AbbVieSynthroid | $36 | $2,08522 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $1,403123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.
Other adult health in Bonita Springs
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.